During the development of in vitro diagnostic reagent project, resource management and risk assessment are key factors to ensure the project success. Especially in the multi-project parallel environment, how to allocate limited resources efficiently and evaluate and control risks reasonably is directly related to the progress and quality of the project. This paper proposes a novel risk assessment model based on analytic Hierarchy Process (AHP) to address this challenge. Firstly, through the comprehensive identification and analysis of the risk factors of in vitro diagnostic reagent project, combined with domestic and foreign related research, a multi-level risk assessment model is constructed. The model divides the risk factors into several levels, and determines the weight of each level through the expert scoring method, so as to realize the priority ranking of different risks. In the empirical study, this study applied the model to the actual in vitro diagnostic reagent project to verify the effectiveness and applicability of the model. The results show that the model based on analytic hierarchy process can significantly improve the accuracy of risk identification, optimize the allocation of resources, reduce the overall risk of the project, and shorten the development cycle. The research in this paper not only provides a systematic risk assessment method, but also provides a feasible solution for enterprises to optimize resource management under multi-project environment, which has important practical value and reference significance.

Fengyi Zhao. Risk Assessment Model and Empirical Study of in Vitro Diagnostic Reagent Project Based on Analytic Hierarchy Process. International Journal of New Developments in Engineering and Society (2024) Vol.8, Issue 5: 76-82. https://doi.org/10.25236/IJNDES.2024.080512.

[1] Ryo N, Sakae S, Fumio Y, et al. Particles, Affinity Particles Having Ligand For Target Substance, In Vitro Diagnostic Reagent And Kit That Include Same, And Method For Detecting Target Substance: EP20200856031[P]. EP4023682A1[2024-09-24].

[2] Prokhvatilova E V, Tkachenko G A, Baturin A, et al. Evaluation of the diagnostic efficacy of a reagent kit for in vitro diagnosis of West Nile fever using reverse transcription polymerase chain reaction with fluorescent probe-based detection[J]. Biological Products. Prevention, Diagnosis, Treatment, 2023. DOI:10.30895/2221-996x-2023-23-1-90-101.

[3] Youpeng Wu, Zhuodong Yang, Yongshou Zhang, et al. Based on the browser and server architecture in vitro diagnostic reagents management system to build [J]. China medical equipment 2024, 21 (6), 121-125, DOI: 10.3969 / j.i SSN. 1672-8270.2024.06.024.

[4] Song D, Sun H, Ma L, et al. In-Vitro Diagnostic Reagent Evaluation of Commercially Available Cardiac Troponin I Assay Kits Using H/D Exchange Mass Spectrometry for Antibody-Epitope Mapping [J]. Biological Products. 2023. DOI:10.1021/acs.analchem.2c03946.

[5] Jia Z, Huang J, Yang Y, et al. Establishing national reference materials for genetic testing of cytochrome P450[J]. Pharmacogenetics and Genomics, 2024, 34(6):175-183. DOI:10.1097/ FPC. 0000000000000532.

[6] Warren P D, Smith M H. Epitope requires structural elements as shown by mass spectroscopy and dual‐site associated kinetics[J]. Journal of Molecular Recognition, 2023, 36. DOI:10.1002/jmr.3011.

[7] Geistanger A, Braese K, Laubender R. Automated data analytics workflow for stability experiments based on regression analysis[J]. Journal of mass spectrometry and advances in the clinical lab, 2022, 24:5-14. DOI:10.1016/j.jmsacl.2022.01.001.

[8] Wei T, Li J, Yue Y. Compositions, Devices, And Methods Of Mitigating Lipoprotein Interference In In Vitro Diagnostic Assays For Hydrophobic Analytes:EP20200773681[P]. EP3941627A1[2024-09-24].

[9] Varatharajah Y, Chen H, Trotter A, et al. A Dynamic Human-in-the-loop Recommender System for Evidence-based Clinical Staging of COVID-19[C]. HealthRecSys@ RecSys. 2020: 21-22.

[10] Cao Y, Cao P, Chen H, et al. Predicting ICU admissions for hospitalized COVID-19 patients with a factor graph-based model [M]. Multimodal AI in healthcare: A paradigm shift in health intelligence. Cham: Springer International Publishing, 2022: 245-256.